weBiom, Korea Food Research Institute

weBiom is a South Korean biotechnology company established in 2021 as a joint venture between Ildong Holdings and the Korea Food Research Institute (KFRI). The company operates as a research institute enterprise focused on the commercialization of microbiome-based technologies for health functional foods and therapeutic applications. weBiom leverages a vast library of functional microbial strains to develop products targeting the gut-brain axis, metabolic health, and immune regulation. Their pipeline includes live biotherapeutic products (LBPs) for indications such as obesity and cognitive decline. By combining KFRI's research capabilities with Ildong's pharmaceutical manufacturing expertise, weBiom aims to lead the next generation of microbiome-derived health solutions.